Market Overview

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Rockwell Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Share:

The
Schall Law Firm
, a national shareholder rights litigation firm,
announces the filing of a class action lawsuit against Rockwell Medical,
Inc. ("Rockwell Medical" or "the Company") (NASDAQ: RMTI)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.

Investors who purchased the Company's shares between March 16, 2018, and
June 26, 2018, inclusive (the "Class Period"), are encouraged to contact
the firm before September 25, 2018.

If you are a shareholder who suffered a loss, click
here to participate
.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm's website at www.schallfirm.com,
or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading
statements to the market. Rockwell Medical had knowledge that the
Centers for Medicare and Medicaid Services would not pursue the
Company's plan for reimbursement for Triferic. The Company's estimated
reserves on form 10-Q for the quarter ending March 31, 2018, were
misstated. Rockwell Medical suffered from material weakness in controls
for financial reporting. Robert L. Chioini, Rockwell's former Chief
Executive Officer, failed to inform the Company's auditors, corporate
counsel, and independent board members with important information about
Triferic. Based on these facts, the Company's public statements about
business operations, prospects, and results were false and materially
misleading throughout the class period. When the market learned the
truth about Rockwell Medical, investors suffered damages.

Join
the case
to recover your losses.

The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.

View Comments and Join the Discussion!